Irith Chemtech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 02-11-2024
- Paid Up Capital ₹ 0.10 M
as on 02-11-2024
- Company Age 3 Year, 13 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 1067.14%
(FY 2023)
- Profit 3825.44%
(FY 2023)
- Ebitda 152.97%
(FY 2023)
- Net Worth 1603.78%
(FY 2023)
- Total Assets 5235.84%
(FY 2023)
About Irith Chemtech
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shrikant Narkhede, Preeti Ghorpade, and Dilip Jagdale serve as directors at the Company.
- CIN/LLPIN
U74140MH2021PTC374126
- Company No.
374126
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Dec 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Irith Chemtech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shrikant Narkhede  | Director | 30-Dec-2021 | Current |
| Preeti Ghorpade | Director | 30-Dec-2021 | Current |
| Dilip Jagdale | Director | 30-Dec-2021 | Current |
Financial Performance of Irith Chemtech.
Irith Chemtech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1067.14% increase. The company also saw a substantial improvement in profitability, with a 3825.44% increase in profit. The company's net worth Soared by an impressive increase of 1603.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Irith Chemtech?
Unlock access to Irith Chemtech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Oasis Rasayan Industries Private LimitedActive 7 months 7 daysShrikant Narkhede and Preeti Ghorpade are mutual person
- Eurocel Chemical Industries Private LimitedActive 2 years 11 months
Shrikant Narkhede is a mutual person
- Rovina Pharma And Intermediate Chemicals Private LimitedActive 5 years 18 days
Shrikant Narkhede is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Irith Chemtech?
Irith Chemtech has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Irith Chemtech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Irith Chemtech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
